Anaphylaxis in the monkey: pulmonary oedema after pre-treatment of beta-receptor stimulants.
Aggregate anaphylaxis was induced in seven ovalbumin-sensitized monkeys, with high tires of ovalbumin specific haemagglutinating antibodies. After pretreatment with an intravenous (i.v.) injection of 0.25 mg/kg terbutaline (n = 6) or an infusion of isoprenaline (n = 1), anaphylactic shock was induced by i.v. challenge with specific antigen. Haemodynamics, regional blood flows, respiratory mechanics, blood gases and haematological changes were studied during the following 30 min. Severe shock developed following ovalbumin challenge and the cardiac output was reduced by a mean of 74%. Pulmonary vascular resistance increased 11-fold. Pulmonary dynamic compliance decreased, but there was only a minor increase in pulmonary resistance. Hypoxaemia and severe metabolic acidosis developed. Circulating platelets and leucocytes decreased markedly. Three animals died with fulminant pulmonary oedema. In conclusion, the reaction pattern was similar to that found in studies of monkeys that received no prior treatment. However, the occurrence of pulmonary oedema suggests that the effects of large doses of terbutaline on the heart, combined with the high pulmonary vascular resistance, resulted in more severe pulmonary changes than took place in untreated animals.
D000136:Acid-Base Equilibrium; D000707:Anaphylaxis / Q000503:physiopathology*; D000818:Animals; D000906:Antibodies; D000882:Haplorhini; D006439:Hemodynamics / Q000187:drug effects*; D007114:Immunization; D007545:Isoproterenol / Q000494:pharmacology; D008251:Macaca; D010047:Ovalbumin / Q000276:immunology; D010313:Partial Pressure; D011654:Pulmonary Edema / Q000209:etiology*; D012039:Regional Blood Flow / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013726:Terbutaline / Q000494:pharmacology*; D014655:Vascular Resistance / Q000187:drug effects
D000906:Antibodies; D010047:Ovalbumin; D007545:Isoproterenol; D013726:Terbutaline